Impact of the COVID-19 outbreak on blood supply in two large university hospitals.
COVID-19
automated solutions
blood donors
laboratory testing
patient blood management
Journal
Transfusion medicine (Oxford, England)
ISSN: 1365-3148
Titre abrégé: Transfus Med
Pays: England
ID NLM: 9301182
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
revised:
08
11
2023
received:
21
06
2023
accepted:
07
01
2024
pubmed:
23
1
2024
medline:
23
1
2024
entrez:
23
1
2024
Statut:
ppublish
Résumé
This study aimed to examine the relationship between the decrease in elective procedures and the need for blood donation during the novel coronavirus disease (COVID-19) pandemic at university hospitals. The COVID-19 pandemic has immensely impacted transfusion medicine. By cancelling elective surgery, the German government hoped to increase the available resources for patients infected with COVID-19, especially in intensive care units, and prevent the shortage of blood products. Over 26 weeks, from the 3rd of February 2020 to the 2nd of August 2020, during the first phase of the pandemic, we assessed the number of crossmatches, blood group typing, use of donated blood, and case mix indices by retrospectively analysing data from two major university hospitals' information systems in Essen and Hamburg, Germany. Data were pooled, analysed, and compared with that of the same period in the previous year. Following the cessation of elective procedures, the number of requests for crossmatches and blood group typing significantly decreased in 2020 compared to that in 2019. However, the number of blood transfusions required was reduced to a lesser extent. The number of outpatient and inpatient cases significantly decreased, whereas the cases requiring transfusion decreased only. During the initial phase of the pandemic, transfusion medicine, especially in large institutions, faced an almost unchanged high demand for donated blood. This should be considered regarding personnel and blood donation allocations. Therefore, we developed a monitoring system to display the availability of blood products in real-time. The quick and easy display of in-stock and expiring blood products can optimise the use of this valuable resource.
Sections du résumé
OBJECTIVE
OBJECTIVE
This study aimed to examine the relationship between the decrease in elective procedures and the need for blood donation during the novel coronavirus disease (COVID-19) pandemic at university hospitals.
BACKGROUND
BACKGROUND
The COVID-19 pandemic has immensely impacted transfusion medicine. By cancelling elective surgery, the German government hoped to increase the available resources for patients infected with COVID-19, especially in intensive care units, and prevent the shortage of blood products.
METHODS/MATERIALS
METHODS
Over 26 weeks, from the 3rd of February 2020 to the 2nd of August 2020, during the first phase of the pandemic, we assessed the number of crossmatches, blood group typing, use of donated blood, and case mix indices by retrospectively analysing data from two major university hospitals' information systems in Essen and Hamburg, Germany. Data were pooled, analysed, and compared with that of the same period in the previous year.
RESULTS
RESULTS
Following the cessation of elective procedures, the number of requests for crossmatches and blood group typing significantly decreased in 2020 compared to that in 2019. However, the number of blood transfusions required was reduced to a lesser extent. The number of outpatient and inpatient cases significantly decreased, whereas the cases requiring transfusion decreased only.
CONCLUSION
CONCLUSIONS
During the initial phase of the pandemic, transfusion medicine, especially in large institutions, faced an almost unchanged high demand for donated blood. This should be considered regarding personnel and blood donation allocations. Therefore, we developed a monitoring system to display the availability of blood products in real-time. The quick and easy display of in-stock and expiring blood products can optimise the use of this valuable resource.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-19Subventions
Organisme : Bundesministerium für Gesundheit
ID : 2519DAT713
Informations de copyright
© 2024 The Authors. Transfusion Medicine published by John Wiley & Sons Ltd on behalf of British Blood Transfusion Society.
Références
Pagano MB, Rajbhandary S, Nunes E, Cohn CS. Transfusion services operations during the COVID-19 pandemic: Results from AABB survey. Transfusion. 2020;60:2760-2762. doi:10.1111/trf.15986
Worrall AP, Kelly C, O'neill A, et al. Transfusion requirements in patients with COVID-19. Eur J Haematol. 2021;106:132-134. doi:10.1111/ejh.13521
Patel A, Jernigan DB, Nco VCDCRT. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak: United States, December 31, 2019-February 4, 2020. Am J Transplant. 2020;2020(20):889-895. doi:10.1111/ajt.15805
German Medical Journal. Berlin: Deutscher Ärzteverlag GmbH; 2020. First case of 2019-nCoV confirmed nationwide. Accessed March 5, 2023 https://www.aerzteblatt.de/nachrichten/108953/Bundesweit-erster-Fall-von-2019-nCoV-bestaetigt
World Health Organization. Geneva World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Updates and Monthly Operational Updates. 2023. Accessed March 5, 2023 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Marin-Mori K, Gonzalez-Gascon YMI, Foncillas-Garcia MA, et al. Blood transfusion activity in a general hospital during the COVID-19 pandemic. Vox Sang. 2021;116:574-580. doi:10.1111/vox.13024
Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7:e671-e678. doi:10.1016/S2352-3026(20)30217-9
Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95:E131-E134. doi:10.1002/ajh.25774
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls; 2023.
Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ. 2021;372:n579. doi:10.1136/bmj.n579
Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372:1-9. doi:10.1126/science.abg3055
Wang P, Casner RG, Nair MS, et al. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. bioRxiv. 2021;29(5):747-751. doi:10.1101/2021.03.01.433466
Carenzo L, Costantini E, Greco M, et al. Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020;75:928-934. doi:10.1111/anae.15072
German Medical Journal. Berlin: Deutscher Ärzteverlag GmbH; 2020. Coronavirus: Hospitals postpone scheduled procedures. Accessed March 5, 2023 https://www.aerzteblatt.de/archiv/213192/Coronavirus-Krankenhaeuser-verschieben-planbare-Eingriffe
Barriteau CM, Bochey P, Lindholm PF, Hartman K, Sumugod R, Ramsey G. Blood transfusion utilization in hospitalized COVID-19 patients. Transfusion. 2020;60:1919-1923. doi:10.1111/trf.15947
UKE Hamburg. Hamburg: University Hospital Hamburg-Eppendorf. The UKE. 2022. Accessed March 12, 2023 https://www.uke.de/allgemein/ueber-uns/das-uke/index.html
University Hospital Essen. Essen: University Medicine Essen. Main focus. 2023. Accessed March 12, 2023 https://www.uk-essen.de/schwerpunkte/
Official city portal for Hamburg. Hamburg: hamburg.de GmbH & Co. KG. Facts & Figures. 2019. Accessed March 12, 2023 https://www.hamburg.de/info/3277402/hamburg-in-zahlen/
UKE Hamburg. Hamburg: University Hospital Hamburg-Eppendorf. Facts and figures: Business figures 2021. 2021. Accessed March 12, 2023 https://www.uke.de/allgemein/ueber-uns/das-uke/zahlen-fakten/index.html
Annual Report. Essen: University Medicine Essen. Accountability report. 2021. Accessed March 12, 2023 https://jahresberichte.ume.de/2022/03/02/rechenschaftsbericht/
Metropolis Ruhr Essen: Regional Association Ruhr. The city of cites. Accessed March 12, 2023 2023 https://metropole.ruhr/metropole
Paul Ehrlich Institute. Langen: Paul Ehrlich Institute. Reports according to § 21 Transfusion Act, TFG. 2021. Accessed March 5, 2023 https://www.pei.de/DE/newsroom/pflichtberichte/21tfg/21-tfg-berichte-node.html;jsessionid=624E40E8D4BC13F34E468E764C6AEBFA.intranet232
Infectious Diseases. Berlin: Robert Koch Institute. Situation reports from Monday to Friday. 2022. Accessed March 5, 2023 https://www.rki.de/EN/Content/infections/epidemiology/outbreaks/COVID-19/Situationsberichte_Tab.html;jsessionid=952DECED12E4BB92F3894B2C97419540.internet051
Mendez CM, Harrington DW, Christenson P, Spellberg B. Impact of hospital variables on case mix index as a marker of disease severity. Popul Health Manag. 2014;17:28-34. doi:10.1089/pop.2013.0002
Von Dercks N, Seehofer D, Steinert M, et al. How severe is the effect of the coronavirus pandemic on the department of surgery of a university hospital?: An analysis of the first 7 weeks. Chirurg. 2020;91:755-761. doi:10.1007/s00104-020-01255-y
Fistera D, Pabst D, Falk M, et al. Wave riding: 12 months of COVID−19 in a German tertiary care center. Dtsch Med Wochenschr. 2022;147:e13-e22. doi:10.1055/a-1522-1502
Koeckerling D, Pan D, Mudalige NL, Oyefeso O, Barker J. Blood transfusion strategies and ECMO during the COVID-19 pandemic. Lancet Respir Med. 2020;8:e40. doi:10.1016/S2213-2600(20)30173-9
Kowalewski M, Fina D, Slomka A, et al. COVID−19 and ECMO: the interplay between coagulation and inflammation-a narrative review. Crit Care. 2020;24:205. doi:10.1186/s13054-020-02925-3
German Medical Journal. Berlin: Deutscher Ärzteverlag GmbH. COVID 19 pandemic: Historically low bed occupancy rate. 2021. Accessed March 12, 2023 https://www.aerzteblatt.de/archiv/218200/COVID-19-Pandemie-Historisch-niedrige-Bettenauslastung
Kuhlen R, Schmithausen D, Winklmair C, Schick J, Scriba P. The effects of the COVID-19 pandemic and lockdown on routine Hospital Care for Other Illnesses. Dtsch Arztebl Int. 2020;117:488-489. doi:10.3238/arztebl.2020.0488
Fan BE, Ong KH, Chan SSW, et al. Blood and blood product use during COVID-19 infection. Am J Hematol. 2020;95:E158-E160. doi:10.1002/ajh.25823
Goh KJ, Wong J, Tien JC, et al. Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies. Crit Care. 2020;24:215. doi:10.1186/s13054-020-02916-4
Murphy C, Jackson B, Fontaine M. Tools for rapid analysis of blood usage and inventory during the COVID-19 pandemic. Transfusion. 2020;60:2199-2202. doi:10.1111/trf.15996
Stanworth SJ, New HV, Apelseth TO, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7:e756-e764. doi:10.1016/S2352-3026(20)30186-1
Schiroli D, Merolle L, Molinari G, et al. The impact of COVID-19 outbreak on the transfusion medicine unit of a northern Italy hospital and cancer Centre. Vox Sang. 2022;117:235-242. doi:10.1111/vox.13174
Argov S, Shechter Y. Is routine crossmatching for two units of blood necessary in elective surgery? Am J Surg. 1981;142:370-371. doi:10.1016/0002-9610(81)90351-2
Faridi S, Ahmad A, Beg MA, Siddiqui F, Edhi MM, Khan M. Arranging blood for elective thyroid surgeries: dilemma continues in the developing world. BMC Res Notes. 2017;10:49. doi:10.1186/s13104-016-2315-9
Mann K, Sim I, Ali T, et al. Removing the need for crossmatched blood in elective EVAR. Eur J Vasc Endovasc Surg. 2012;43:282-285. doi:10.1016/j.ejvs.2011.11.026
Ammar W, Khalife J, El-Jardali F, et al. Hospital accreditation, reimbursement and case mix: links and insights for contractual systems. BMC Health Serv Res. 2013;13:505. doi:10.1186/1472-6963-13-505
Wang Y, Han W, Pan L, et al. Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang. 2020;115:502-506. doi:10.1111/vox.12931
Greinacher A, Fendrich K, Hoffmann W. Demographic changes: the impact for safe blood supply. Transfus Med Hemother. 2010;37:141-148. doi:10.1159/000313949
Greinacher A, Weitmann K, Schonborn L, et al. A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand. Blood Adv. 2017;1:867-874. doi:10.1182/bloodadvances.2017005876